ÍÆ¼ö¸øºÃÓÑ ÉÏһƪ | ÏÂһƪ

²¿·ÖÆ¢¶¯Âö˨ÈûµÄÁÙ´²Ó¦ÓÃ

[ÕªÒª]Ä¿µÄ ʹÓò»Í¬Ë¨Èû²ÄÁϽøÐÐPSEµÄÁÆÐ§ÆÀ¼Û¡£²ÄÁϺͷ½·¨ ¸÷ÖÖÔ­ÒòËùÖÂÆ¢¿º»¼Õß55Àý£¬ÄÐÐÔ41Àý£¬Å®ÐÔ14Àý£¬ÆäÖиÎÓ²»¯Ãž²Âö¸ßѹ֢42Àý£¨²¢ºÏ¸Î°©25Àý£©£¬¸ÎÒÆÖ²Êõºó3Àý£¬²¼¼Ó×ÛºÏÖ¢2Àý£¬Ô­·¢ÐÔѪС°å×Ïñ°6Àý£¬¸ÉÔï×ÛºÏÖ¢2Àý¡£Ê¹Óõ¯»ÉȦ¡¢PVA¿ÅÁ£¼°Ã÷½ºº£Ãà¿ÅÁ£½øÐÐPSE£¬¹Û²ìÊõºóÆ¢Ôà˨Èû³Ì¶È£¬¶ÔѪ³£¹æ¡¢¸Î¹¦ÄܵÄÓ°Ï죬Êõºó²¢·¢Ö¢µÄ·¢ÉúÂʵȡ£½á¹û Êõºó°×ϸ°û¡¢ÑªÐ¡°å¡¢ºìϸ°û¾ùÓÐÃ÷ÏÔ¸ÄÉÆ¡£1¸öÔÂ×óÓÒ¸´²éÞ²ÂöÄÚ¾¶ËõС£»Æ¢Ôà´óС²»Í¬³Ì¶ÈËõС¡£ÊõºóÎÞÑÏÖØ²¢·¢Ö¢·¢Éú¡£½áÂÛ ²¿·ÖÆ¢¶¯Âö˨ÈûÊÇÖÎÁÆÆ¢¹¦ÄÜ¿º½ø°²È«ÓÐЧµÄ·½·¨£¬µ¥´¿Ê¹Óõ¯»ÉȦ˨ÈûÖÎÁÆÓë¿ÅÁ£Ë¨Èû±È½Ï£¬ÁÆÐ§ÎÞÃ÷ÏÔ²îÒ죬»¼ÕßÊõºó·´Ó¦½ÏÇᣬÒ×ÓÚ½ÓÊÜ¡£

[¹Ø¼ü´Ê] Æ¢¹¦ÄÜ¿º½ø£»Æ¢£»Ë¨ÈûÊõ£»½éÈëÖÎÁÆ

 [Abstract]Objective  To evaluate clinical efficacy of partial splenic embolization on patients suffering from hyperslenism. Methods  55 cases of patients suffering from hypersplenism were collected, including hepatic cirrhosis accompanied by portal hypertension 42cases ( with hepatic carcinoma, n=25), post-liver transplantation 3 cases, Budd-Chiari syndrome 2 cases, thrombocytopathic purpura 2 cases, primary Sjogren's Syndrome 2 cases. All patients received PSE in which Gelatin sponge, metal coil, PVA particulate were choosed as embolization materials. On 3 days,1 week, 1 month, 6 months ,1 year after operation, the blood routine examination was carried out. And CT scan of spleens were performed. Results :After operation leucocytes and thrombocytes and red blood cells all ascend. The sizes of spleen reduced by CT scan. No severe complication occured.
Conclusion :The curative effect of partial splenic embolization is safe and efficacy. There may be more comfortable and less complication using metal coil as embolization  materials.It is preferable to enlarge the area of embolization if the patient¡¯s condition permits for steady the efficacy.

¡¾Key words¡¿¡¡Hypersplenism; Spleen ; Embolization ; Interventional radiology

²¿·ÖÐÔÆ¢Ë¨ÈûÊõ(partial splenic embolization, PSE)ÓÉÓÚÆä´´ÉËС£¬ÊÊÓ¦Ö¤¹ã£¬ÔÚ¾ÀÕýÆ¢¹¦ÄÜ¿º½ø¡¢¼õÉÙÃÅÂöѪÁ÷µÄͬʱ±£ÁôÁËÆ¢ÔàµÄÃâÒß¹¦Äܺ͹ýÂ˹¦ÄÜ£¬ÒÑÔÚÁÙ´²¹ã·ºÓ¦Ó㬶à²ÉÓÃÃ÷½ºº£Ãà¡¢PVA¿ÅÁ£¡¢µ¯»ÉȦµÈ²ÄÁÏ£¬ÏÖ½éÉÜÎÒÔºPSEÖÎÁƾ­ÑéÈçÏ¡£

²ÄÁϺͷ½·¨
1Ò»°ã×ÊÁÏ  ¸÷ÖÖÔ­ÒòËùÖÂÆ¢¿º»¼Õß55Àý£¬ÄÐÐÔ41Àý£¬Å®ÐÔ14Àý£¬ÄêÁä27~77Ë꣬ÖÐλֵ51Ë꣬¾ù¾­²¡Ê·¡¢ÁÙ´²ºÍʵÑéÊÒ¼ì²é¡¢B³¬¡¢±µ²Í¡¢CT¡¢Ñª¹ÜÔìÓ°¼ì²éÈ·Õï¼Ì·¢Æ¢¿º¡£¸ÎÓ²»¯Ãž²Âö¸ßѹ֢42Àý£¬ÆäÖкϲ¢¸Î°©25Àý£¬ºÏ²¢Ê³µÀθµ×¾²ÂöÇúÕųöѪ7Àý¡£¸ÎÒÆÖ²Êõºó3Àý£¬²¼¼Ó×ÛºÏÖ¢2Àý£¬Ô­·¢ÐÔѪС°å×Ïñ°6Àý£¬¸ÉÔï×ÛºÏÖ¢2Àý¡£±¾×é¸ÎÓ²»¯²¡Àý¸ù¾ÝÁÙ´²×ÊÁÏ(ÒҸβ¡Ê·£¬Óиι¦ÄܼõÍ˼°ÃÅÂö¸ßѹÁÙ´²±íÏÖ£¬¸Î¹¦ÄÜÓйØÖ¸±êºÍ/»ò²¡Àí»î¼ìµÈ)ºÍÓ°Ïñѧ×ÊÁÏ(³¬Éù»òCT¡¢MRµÈ)×ÛºÏÕï¶Ï¡£Æ¢¹¦ÄÜ¿º½ø¸ù¾ÝÓ°Ïñѧ×ÊÁÏ(³¬Éù»òCT¡¢MR)ʾƢÔàÃ÷ÏÔÔö´ó£¬ÊõǰÖÜΧѪϸ°û¼ÆÊýʾÈýϵϸ°ûÃ÷ÏÔ½µµÍ£¬ÒÔ°×ϸ°ûºÍѪС°å½µµÍÓÈΪÏÔÖø£¬»¼ÕßÒ׸ÐȾ£¬ÓгöѪÇãÏòµÈÕï¶Ï¡£ÊõǰÊõºó³£¹æ±£»¤¸Î¹¦Äܼ°Ö§³ÖÖÎÁÆ£¬²¢²ÉÓÿ¹ÉúËØ¿¹¸ÐȾµÈ¡£
2·½·¨ PSE£ºDSAϲÉÓÃSeldinger·¨´©´Ì¹É¶¯Âö²å¹Ü£¬½«4~5Fµ¼¹Ü²åÈëÆ¢¶¯Âö£¬Ìõ¼þÔÊÐíʱ£¬Ñ¡ÔñÆ¢Ò¶¶¯Âö£¬»ºÂýÍÆ×¢300~500¦Ì´óСPVA¿ÅÁ£»ò1 mm x l mm x l mmÃ÷½ºº£Ãà¿ÅÁ£»òÖ±¾¶3mm~5mmµÄµ¯»ÉȦ£¬Ë¨ÈûÃæ»ýÔÚ40%~60%¡£µ¥´¿Ê¹Óõ¯»ÉȦÖÎÁÆ×é34Àý¡¢ºÍPVA¿ÅÁ£Ë¨Èû6Àý£¬Ã÷½ºº£Ãà¿ÅÁ£Ë¨Èû15Àý£¬¹Û²ìÊõºóÆ¢Ôà˨Èû³Ì¶È£¬¶ÔѪ³£¹æ¡¢¸Î¹¦ÄܵÄÓ°Ï죬Êõºó²¢·¢Ö¢µÄ·¢ÉúÂʵȡ£

½á  ¹û
ËùÓв¡ÀýDSAÏÔʾƢ¶¯Âö·ÖÖ§Ã÷ÏÔ¼õÉÙÆ¢ÊµÖÊÄڿɼûÐÎ×´´óС²»Ò»µÄÔìӰȾɫȱËðÇø£¬Êõºó1- 2¸öÔÂCTɨÃ裬ËùÓв¡ÀýÆ¢ÔàʵÖÊÄÚ¾ù¿É¼ûÐÎ̬²»Í¬µÍÃܶȹ£ËÀÇø£¬¾Ö²¿»µËÀÒº»¯Ã÷ÏÔ£¬Æ¢Ôà´óС²»Í¬³Ì¶ÈËõС¡£1Äêºó¸´²é¸¹²¿CTÆ¢ÔàÆ½¾ùËõСԼ2¸öÀßµ¥Ôª¡£¸ÎÓ²»¯ºÏ²¢Ãž²Âö¸ßѹ»¼ÕßÊõºóCTÏÔʾÞ²ÂöÄÚ¾¶ËõСÖÁ1. 0~1.5cm£¬7ÀýºÏ²¢ÓÐʳµÀθµ×¾²ÂöÇúÕŵϼÕßÖÐ1ÀýÔٴγöÏÖÉÏÏû»¯µÀ³öѪ£¬ÐèÒª½øÐÐʳµÀθµ×¾²Âö˨ÈûÖÎÁÆ£¬ÆäÓà6Àýδ¼û³öѪÇãÏò¡£
Êõºó·Ö±ðÓÚµÚ3ÌìºÍµÚ1ÖÜ¡¢µÚ4ÖÜ¡¢6¸öÔ¼°1Ä긴²é°×ϸ°û¡¢ÑªÐ¡°å¡¢ºìϸ°û£¬¾ùÓÐÃ÷ÏÔ¸ÄÉÆ£¬Èç±í1¡£3¸öÔÂ~°ëÄêÄÚѪϸ°ûÔÙ´ÎϽµ9Àý£¬ÆäÖÐ7ÀýΪ¸ÎÓ²»¯ºÏ²¢¸Î°©»¼Õߣ¬2ÀýΪ×ÔÉíÃâÒß²¡¡£
²¢·¢Ö¢: ˨Èûºó1~3 d·¢Éú¸ßÈÈÕß3Àý£¬ÌåÎÂ>39¡æ£¬¾ùΪÃ÷½ºº£Ãà¿ÅÁ£Ë¨Èû£¬¶àÊýÌåÎÂ>38¡æ£¬Æ½¾ù³ÖÐø1~2ÖÜ¡£ÌÛÍ´Ö÷ÒªÒÔÇ£³¶ÌÛΪÖ÷£¬¶àÊýΪÇá-ÖжÈÌÛÍ´£¬³ÖÐøÊ±¼äƽ¾ù2ÖÜ£¬¶à²ÉÓöþ¼¶ÕòÍ´Ò©ÎïÖÎÁÆ£»ÖضÈÌÛÍ´Õß5Àý£¬ÆäÖÐ4ÀýʹÓÃPVA¿ÅÁ££¬1ÀýΪÃ÷½ºº£Ãà¿ÅÁ£Ë¨Èû£¬¾ùÐë²ÉÓÃ3¼¶ÕòÍ´Ò©ÎïÖÎÁÆ¡£2Àý»¼Õß²¢·¢×ó²àÉÙÁ¿ÐØË®£¬¿¼ÂÇΪ·´Ó¦ÐÔÉø³öÐÔÐØÄ¤Ñס£1Àý»¼Õß³öÏÖÆ¢ÄÒÖ×£¬Î´²¢·¢Æ¢Å§Ö×£¬¾­´©´ÌÒýÁ÷ºóÎüÊÕ¡£ÎÞ¼±ÐÔÒÈÏÙÑ×·¢Éú¡£µ¯»ÉȦÖÎÁÆ×éÌåζàµÍÓÚ39¡æ£¬ÌÛÍ´¸Ð¾õÇá¡£

ÌÖ  ÂÛ
1973 ÄêMadidson Ê×´ÎÓ¦ÓýéÈë·ÅÉä¼¼Êõ×÷ȫƢ¶¯Âö˨Èû£¬µ«Êõºó¾ø´ó²¿·Ö³öÏÖÆ¢Å§Ö×£¬²¡ËÀÂʼ«¸ß¡£Ö±µ½1979 ÄêSpigos µÈÓ¦Óò¿·ÖƢ˨ÈûÊõ(PSE) ³É¹¦ÖÎÁÆÆ¢¹¦ÄÜ¿º½øºó£¬PSE ²ÅÖð½¥ÎªÁÙ´²½ÓÊÜ¡£²¿·ÖÆ¢¶¯Âö˨Èû¿ÉÒÔ½â¾ö¶àÖÖÁÙ´²¼²²¡µÄÖ¢×´£¬ÈçÆ¢ÍâÉ˳öѪ¡¢Ô­·¢ÐÔÆ¢¿º¡¢Ãž²Âö¸ßѹ֢¡¢Æ¢¶¯ÂöÁö¡¢Æ¢ÔàÖ×ÁöµÈµÈ¡£PSE ºó²¿·ÖÆ¢×é֯ȱѪ¹£ËÀ£¬Æ¢Ôà¼õÈݿɲ¿·ÖÏ÷ÈõÆ¢ÔàÆÆ»µÑªÏ¸°ûºÍ²úÉúѪϸ°ûÏà¹Ø¿¹ÌåµÄ¹¦ÄÜ£¬´Ó¶ø´ïµ½ÖÎÁÆÆ¢¿ºµÄÄ¿µÄ£»¶ÔÓÚ¸ÎÓ²»¯ÃÅÂö¸ßѹÐÔÆ¢¿º²¡ÈË£¬PSE ¿É¼õÉÙÆ¢¾²ÂöѪÁ÷£¬´Ó¶ø½µµÍÁËÞ²ÂöѹÁ¦ºÍ¼õÉÙÇúÕž²ÂöÆÆÁѳöѪµÄ·çÏÕ[1]¡£ÇÒ²¡È˸ι¦ÄÜÒ²Äܵõ½¸ÄÉÆ[2]¡£¶ÔÓÚ¸ÎÓ²»¯ºÏ²¢¸Î°©°éÆ¢¹¦ÄÜ¿º½ø»¼ÕßÍùÍùÓÉÓÚÆ¢¹¦ÄÜ¿º½øËùÖµÄÍâÖÜѪϸ°ûÃ÷ÏÔµÍÓÚÕý³££¬ÔÙ¼ÓÉϸζ¯Âö¹à×¢»¯ÁÆË¨Èûºó¹ÇËèÒÖÖÆ£¬Ê¹ÍâÖÜѪϸ°û½øÒ»²½½µµÍ£¬´Ó¶øÓ°Ïì¼ÌÐøÖÎÁÆ£¬²¿·ÖÐÔÆ¢¶¯Âö˨Èû£¬Ê¹ÆäѪϸ°û»Ö¸´Õý³££¬ÔöÇ¿ÁË»¼ÕßµÄÃâÒß¹¦ÄÜ£¬ÒÔ±ãÄܽøÒ»²½Ðиζ¯Âö»¯ÁÆ[3]¡£
PSEµÄÖ÷ҪĿµÄÊÇËõСƢÔàÌå»ý£¬½µµÍÃÅÂöѹÁ¦£¬¼õÉÙѪϸ°ûµÄÆÆ»µ¡£Ë¨ÈûÆ¢ÔàÃæ»ý¿ØÖÆÔÚ¶àÉÙ½ÏΪºÏÊÊ£¬¹úÄÚÍâѧÕß¶àÈÏΪ²¿·ÖÆ¢¶¯Âö˨ÈûÃæ»ý´ïµ½Æ¢ÔàÃæ»ýµÄ50%-70%ʱ¿ØÖÆÆ¢¹¦ÄÜ¿º½ø½ÏΪÀíÏ룬ͬʱÓÖ±£ÁôÆäÃâÒß¹¦ÄÜ£¬µÍÓÚ50 %Õß²»ÄÜ»º½âÆ¢¿º[4]¡£¶ÔÓÚ¾ÞÆ¢ÒÔÉÙÁ¿¶à´Î˨ÈûΪ¼Ñ£¬¶àÊý²¡ÈË1¡«2 ´ÎPSE ¾Í×ã¹»ÓÐЧµØ¿ØÖÆÆ¢¿º¡£Ò»´ÎÐÔ˨Èû80%ÒÔÉÏÈÝÒ×·¢ÉúƢŧÖ׺ÍÓÕ·¢¸ÎË¥¡£ÈÏʶƢ¶¯Âö·Ö²¼¶ÔÓÚ¿ØÖÆÆ¢ÔàÌå»ýÓм«´ó°ïÖú[5,6]£¬Æ¢¶¯Âö×ßÐÎÓØÇú£¬·ÖÖ§½Ï¶àÇÒ¸´ÔÓ£¬²¿·ÖÆ¢¶¯ÂöÖ÷¸ÉÖÐÍâ¶Î·Ö³öÉÏϼ«¶¯Âö£¬ËæºóÖ÷¸ÉÔÚÆ¢ÃŸ½½ü·Ö³öµÚÒ»¼¶·ÖÖ§, ¼´Æ¢Ò¶¶¯Âö(Æ¢ÉÏ¡¢ÖС¢ÏÂÒ¶¶¯Âö)£¬Ò¶¶¯ÂöÔÙ·¢³ö1~3 Ìõ¶Î¶¯Âö, Æ¢¶Î¶¯Âö»¹¿É·Ö³öÑǶζ¯Âö£¬¸÷Ò¶¡¢¶Î¡¢ÑǶμäѪ¹ÜÎǺϼ«ÉÙ£¬µ±Ë¨ÈûijҶ֧»ò¶ÎÖ§ºó, ÏàÓ¦ÇøÓòµÄÆ¢Ôà×éÖ¯¾Í»á·¢ÉúȱѪ¹£ËÀ¡£ÒÈβ¶¯Âöͨ³£·¢×ÔÆ¢¶¯ÂöÖ÷¸ÉÖÐÍâ¶Î»òƢϼ«¶¯Âö£¬Ó¦±ÜÃâÎó˨ÒÈβ¶¯Âö¡£ÎÒÃǵľ­ÑéÊǽ«µ¼¹Ü²åÖÁ¸¹Ç»¶¯Âö£¬ÏÈÔìÓ°ÁË½âÆ¢¶¯Âö×ßÐм°·ÖÖ§£¬½«µ¼¹ÜÍ·¶ËÖÃÈëÆ¢¶¯ÂöÖÐÍâ¶Î(ÐèÔ½¹ýÒȱ³¶¯Âö¿ª¿Ú)£¬ÓÐÌõ¼þ¿ÉʹÓÃ΢µ¼¹ÜÔÙ³¬Ñ¡ÔñÖÃÈëÆ¢Ò¶¶¯Âö»ò·ÖÖ§£¬Ö÷Ҫ˨ÈûƢϼ«¼°ÍâÖܲ¿£¬ÊÍ·Å˨Èû²ÄÁÏ¡£ÎÒÃÇÔÚ˨ÈûʱעÒâ±ÜÃâ˨ÈûÆ¢Éϼ«¶¯Âö£¬¿ÉÔ¤·ÀÒò˨ÈûºôÎüϵͳ²¢·¢Ö¢Èç·Î²¿¸ÐȾ¡¢ÐØÇ»»ýÒºµÈ¡£
Ŀǰ½éÈë˨Èû¿ÉÑ¡ÔñµÄ²ÄÁϺܶ࣬Ö÷ÒªÓÐPVA¿ÅÁ£¡¢Ã÷½ºº£Ãà¡¢½ðÊôµ¯»ÉȦµÈ[7]£¬PVA¿ÅÁ£½Ïϸ³£ÓÃ×÷ºìËèС¶¯Âö˨Èû£¬Ê¹Ë¨Èûˮƽ´ïµ½ÎǺÏÖ§ÒÔÔ¶£¬ÉõÖÁÆ¢ñ¼Ë®Æ½£¬¼õÉÙÒòÎǺÏÖ§¹©Ñªµ¼ÖÂÆ¢¿º¸´·¢µÄ¿ÉÄÜ£¬ÁÆÐ§¿É¿¿£¬µ«»¼Õß³öÏÖÖØ¶ÈÌÛÍ´¼¸ÂÊ´ó£»Ã÷½ºº£Ãà¿ÅÁ£ÊÇÖÐÆÚ˨Èû²ÄÁÏ£¬Ïà¶ÔÂԴ󣬵«¿É¼°Æ¢¶Î¶¯Âö¼°ÒÔÔ¶´¦Ë¨Èû£¬µ±´óÃæ»ý˨Èû£¬¶Ìʱ¼ä×è¶ÏѪҺ¹©Ó¦¼´¿ÉÒýÆðÏàÓ¦µÄÆ¢¶ÎÓÀ¾ÃÐÔ¹£ËÀ£¬ÔÚÃ÷½ºº£ÃàÎüÊÕǰƢ×éÖ¯ÔçÒÑ·¢Éú¹£ËÀ¡£µ«ÓÉÓÚ˨ÈûÇøÓò·Ö²¼²»¾ù£¬Êõºó¿ÉÄÜÓвà֦ѭ»·½¨Á¢£¬½á¹ûʹʵ¼Ê˨Èû³Ì¶È½ÏÔ¤ÆÚ˨Èû³Ì¶ÈС£¬³£³£Êǵ¼ÖÂÆ¢¿º²»Í¬³Ì¶È¸´·¢µÄÔ­Òò£¬¶øÇÒÊõºó·¢ÈȽ϶ࡢ½ÏÖØ£¬±¾×éÖÐ3Àý³öÏÖ¸ßÈÈ£¬·¢ÉúÂʽϸߣ¨20%£¬3/15£©¡£¶øµ¯»ÉȦ˨ÈûѪ¹ÜÏà¶Ô½Ï´ó£¬³£³£Ö»ÄÜ×öÆ¢Ò¶¶Î˨Èû£¬Ëæ»úÐԽϴ󣬱¾×éÒ»Àý»¼Õßµ¯»ÉȦ˨ÈûÖÁÆ¢ÉÏÒ¶¶¯Âö£¬Êõºóδ·¢ÉúÑÏÖØºôÎüϵͳ²¢·¢Ö¢¡£
PSE³£¼û²¢·¢Ö¢[1,3,4,6,7]°üÀ¨·¢ÈÈ¡¢¸¹Í´ºÍŻ͵ȣ»ÑÏÖØ²¢·¢Ö¢°üÀ¨ÐØÇ»»ýÒº¡¢¸¹Ë®¡¢Ðظ¹Ç»¸ÐȾ¡¢¸ÎË¥¡¢Æ¢Å§Ö×¼°Æ¢ÆÆÁÑ¡£ÎÒÃÇÈÏΪÊõÖÐÑϸñÎÞ¾ú²Ù×÷£¬Ñ¡ÔñÊʵ±µÄ˨ÈûÃæ»ý£¬ÊõºóÁ¢¼´²ÉÓñ£¸ÎÖÎÁÆ£¬¾²Âö¸øÓè½ÏÇ¿Èý´ú¹ãÆ×¿¹ÉúËØÔ¤·À¸ÐȾ£¬¿ÉÓÐЧ±ÜÃâÈçÆ¢Å§Öס¢°ÜѪ֢ºÍ·ÎÑ×µÈÑÏÖØ²¢·¢Ö¢·¢Éú¡£
×ÜÖ®£¬²¿·ÖÆ¢¶¯Âö˨ÈûÊÇÖÎÁÆÆ¢¹¦ÄÜ¿º½ø°²È«ÓÐЧµÄ·½·¨£¬ÈýÖÖ˨Èû²ÄÁÏÖУ¬µ¥´¿Ê¹Óõ¯»ÉȦ˨ÈûÖÎÁÆ»¼ÕßÊõºó·´Ó¦½ÏÇᣬÒ×ÓÚ½ÓÊÜ£¬µ±È»ÓÉÓÚ¸÷×鲡Àý²»¶à£¬ÈÔÓдý½øÒ»²½Ö¤Êµ¡£

²Î¿¼ÎÄÏ×
1. Shimizu T, Onda M, Tajiri T, et al. Bleeding portal-hypertensive gastropathy managed successfully by partial splenic embolization[J]. Hepatogastroenterology, 2002, 49(46): 947 - 949.
2. Murata K, Shiraki K, Takase K, et al .Long term follow-up for patients with liver cirrhosis after partial splenic embolization[J]. Hepatogastroenterol, 1996, 43(11) :1212 - 1217.
3. Å·ÑôÇ¿¡¡Ð¤ÏæÉú¡¡¶­Î°»ª£¬µÈ£¬²¿·ÖÐÔÆ¢Ë¨ÈûÖÎÁƸΰ©»¼Õ߯¢¹¦ÄÜ¿º½øµÄÁÆÐ§¹Û²ì[J].½éÈë·ÅÉäѧÔÓÖ¾£¬2003 £¬12£¨4£©£º273~275
4. Sakai T , Shiraki K, Inoue H , et al . Complications of partial splenic embolization in cirrhotic patients[J]. Dig Dis Sci , 2002 ,47(2) :388 - 391.
5. Å·ÑôËÄУ¬ÅíÌïºì£¬Ì·½¨¹ú£¬µÈ.²¿·ÖƢ˨ÈûÊõµÄ½âÆÊÓëÁÙ´²Ñо¿[J].½âÆÊÓëÁÙ´²£¬2006£¬11 £¨4 £©£º229~231
6. ºÎÖ¾Ã÷£¬Ð»Ïþ¶«£¬ÑÁú£¬µÈ.ºÖÔ彺΢Çò¼°Ã÷½ºº£ÃàÔÚÆ¢Ë¨ÈûÊõÖеÄÁÙ´²Ó¦ÓÃ[J].ÖйúÁÙ´²Ò½Ñ§Ó°ÏñÔÓÖ¾£¬2007 £¬18 £¨5 £©£º336~339
7. David C. Madoff, Alban Denys, Michael J. Wallace, et al. Splenic Arterial Interventions: Anatomy, Indications, Technical Considerations, and Potential Complications[J]. Radio Graphics£¬2005£¬25:191¨C211

±í1    2×黼ÕßÊÖÊõǰºóѪ³£¹æ¼ì²â½á¹û(x¡Às)

×é±ð

Êõǰ

Êõºó3D

1ÖÜ

1¸öÔÂ

6¸öÔÂ

12¸öÔÂ

WBC£¨x109/L£©

2.53¡À0.46

5.06¡À2.02

6.83¡À1.63

4.94¡À1.69

5.05¡À1.29

4.81¡À1.61

RBC£¨x1012/L£©

3.28¡À0.43

3.95¡À0.77

4.20¡À0.65

4.12¡À0.47

4.14¡À0.29

3.98¡À0.32

PLT£¨x109/L£©

33.0¡À6.9

53.3¡À18.1

64.9¡À21.2

68.7¡À16.6

61.7¡À13.6

63.9¡À15.7

ͼ1Ñ¡ÔñÆ¢¶¯ÂöÔìÓ°£¬¿É¼ûÆ¢¶¯ÂöÓØÇú£¬Î´¼ûÆ¢ÉÏϼ«Ñª¹ÜÏÔÓ°£¬Æ¢Ò¶¶Î¶¯ÂöÏÔÓ°ÇåÎú£¬¿É¼ûÎÞѪ¹ÜÇø¡£
 Í¼1
ͼ2Ñ¡ÔñÆ¢ÏÂÒ¶¶¯Âö£¬ÔìÓ°¿É¼ûÔ¼Õ¼50%´óС£¬·ÅÖõ¯»ÉȦ¡£
 Í¼2
ͼ3¡¢4·ÅÖõ¯»ÉȦºóÔìÓ°£¬¿É¼û¶ÎÒÔÏÂѪ¹ÜδÏÔÓ°£¬ÊµÖÊÆÚ¿É¼ûȱËðÇø¡£
 Í¼3    
 Í¼4





TAG: ½éÈëÖÎÁÆ Æ¢¹¦ÄÜ¿º½ø Æ¢ ˨ÈûÊõ
 

ÆÀ·Ö£º0

ÎÒÀ´ËµÁ½¾ä

seccode